HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis.

AuthorsGiovanna Riolo, Tanveer E Towheed
JournalThe Journal of rheumatology (J Rheumatol) Vol. 39 Issue 1 Pg. 192-4 (Jan 2012) ISSN: 0315-162X [Print] Canada
PMID22210682 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
Topics
  • Adalimumab
  • Adult
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antibodies, Monoclonal, Humanized (adverse effects, therapeutic use)
  • Antirheumatic Agents (adverse effects, therapeutic use)
  • Crohn Disease (drug therapy, immunology)
  • Dermatomyositis (chemically induced, pathology)
  • Edema (chemically induced)
  • Fasciitis (chemically induced, pathology)
  • Humans
  • Infliximab
  • Magnetic Resonance Imaging
  • Male
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: